These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18840863)
1. The European pharmaceutical industry: coming to a screen near you? Rutter P; Gilbody S J R Soc Med; 2008 Oct; 101(10):485-8. PubMed ID: 18840863 [No Abstract] [Full Text] [Related]
2. Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June. Silversides A CMAJ; 2009 Jul; 181(1-2):E5-6. PubMed ID: 19581607 [No Abstract] [Full Text] [Related]
3. The Future of Drug-Pricing Transparency. Feldman WB; Rome BN; Avorn J; Kesselheim AS N Engl J Med; 2021 Feb; 384(6):489-491. PubMed ID: 33440087 [No Abstract] [Full Text] [Related]
4. Direct-to-consumer advertising of prescription drugs: European Commission persists in putting industry's interests first. Prescrire Int; 2013 Jan; 22(134):24-5, 27. PubMed ID: 23373084 [TBL] [Abstract][Full Text] [Related]
5. How to misinform patients. Drug Ther Bull; 2009 Aug; 47(8):85. PubMed ID: 19654416 [No Abstract] [Full Text] [Related]
6. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis. Czerw A; Religioni U Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622 [TBL] [Abstract][Full Text] [Related]
7. Drug companies expected to get more leeway in communicating with patients in Europe. Sayburn A BMJ; 2007 Dec; 335(7632):1228. PubMed ID: 18079527 [No Abstract] [Full Text] [Related]
8. Direct-to-consumer drug information in Europe. Ager B Lancet; 2007 Mar; 369(9564):822. PubMed ID: 17350444 [No Abstract] [Full Text] [Related]
9. Europe reconsidering DTCA. Meek C CMAJ; 2007 May; 176(10):1405. PubMed ID: 17485687 [No Abstract] [Full Text] [Related]
10. Direct-to-consumer advertising under fire. Bull World Health Organ; 2009 Aug; 87(8):576-7. PubMed ID: 19705005 [TBL] [Abstract][Full Text] [Related]
11. Belgium to tighten drug advertising laws. Watson R BMJ; 2006 May; 332(7550):1110. PubMed ID: 16690651 [No Abstract] [Full Text] [Related]
12. The new pharmaceutical regulatory procedures for Europe. Jefferys DB Trends Pharmacol Sci; 1995 Jul; 16(7):226-31. PubMed ID: 7667896 [TBL] [Abstract][Full Text] [Related]
13. Europe faces worsening medicine shortages. Hyde R Lancet; 2020 Feb; 395(10223):481-482. PubMed ID: 32061283 [No Abstract] [Full Text] [Related]
14. Drug companies and the public. EC proposal can be defeated. Redding D BMJ; 2009 Jan; 338():b291. PubMed ID: 19174441 [No Abstract] [Full Text] [Related]
16. Merck to pay $58m in settlement over rofecoxib advertising. Charatan F BMJ; 2008 May; 336(7655):1208-9. PubMed ID: 18511780 [No Abstract] [Full Text] [Related]
17. FDA warning to manufacturers of AIDS drugs. Josefson D BMJ; 2001 May; 322(7295):1143. PubMed ID: 11348904 [No Abstract] [Full Text] [Related]
18. The pharmaceutical industry and disease mongering. Will industry's latest moves promote public health or private profit? McKechnie S BMJ; 2002 Jul; 325(7357):216; author reply 216. PubMed ID: 12143862 [No Abstract] [Full Text] [Related]
19. Proposal to allow drug companies to give information to public sparks outcry. Watson R BMJ; 2008 Dec; 337():a3043. PubMed ID: 19088139 [No Abstract] [Full Text] [Related]
20. Whatever happened to the Norwegian Medical Need Clause? Lessons for current debates in EU pharmaceutical regulation. Brooks E; Geyer R Sociol Health Illn; 2016 May; 38(4):576-91. PubMed ID: 26564268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]